Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Fauser

Showing results (81-90 of 237) with videos related to

Pageof 24
Sort By:
Journal of Neuroinflammation|May 1, 2015
Activated microglia/macrophage whey acidic protein (AMWAP) inhibits NFκB signaling and induces a neuroprotective phenotype in microgliaAlexander Aslanidis, Marcus Karlstetter, Rebecca Scholz, et al.
Investigative Ophthalmology & Visual Science|December 15, 2020
The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With AgeTina Schick, Laura Lorés-Motta, Lebriz Altay, et al.
Investigative Ophthalmology & Visual Science|July 31, 2014
Nongenetic risk factors for neovascular age-related macular degenerationTina Ristau, Lebriz Ersoy, Moritz Hahn, et al.
Patient Preference and Adherence|June 29, 2016
Using qualitative research to facilitate the interpretation of quantitative results from a discrete choice experiment: insights from a survey in elderly ophthalmologic patientsVera Vennedey, Marion Danner, Silvia Maa Evers, et al.
Trials|July 18, 2018
Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trialFriederike Schaub, Robert Hoerster, Petra Schiller, et al.
Plos One|June 4, 2016
Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity StagesTina Schick, Lebriz Altay, Eva Viehweger, et al.
The British Journal of Ophthalmology|July 2, 2011
No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohortPhilipp S Muether, Angela Kribs, Moritz Hahn, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 23, 2012
Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real lifeKatharina M Droege, Philipp S Muether, Manuel M Hermann, et al.
Retina (Philadelphia, Pa.)|July 19, 2011
Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachmentSabine Schröder, Philipp S Muether, Albert Caramoy, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 18, 2013
Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration - monthly injections versus pro re nataKatharina M Droege, Albert Caramoy, Andreas Kersten, et al.
Pageof 24

Showing results (81-90 of 237) with videos related to

Sort By:
Pageof 24
Journal of Neuroinflammation|May 1, 2015
Activated microglia/macrophage whey acidic protein (AMWAP) inhibits NFκB signaling and induces a neuroprotective phenotype in microgliaAlexander Aslanidis, Marcus Karlstetter, Rebecca Scholz, et al.
Investigative Ophthalmology & Visual Science|December 15, 2020
The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With AgeTina Schick, Laura Lorés-Motta, Lebriz Altay, et al.
Investigative Ophthalmology & Visual Science|July 31, 2014
Nongenetic risk factors for neovascular age-related macular degenerationTina Ristau, Lebriz Ersoy, Moritz Hahn, et al.
Patient Preference and Adherence|June 29, 2016
Using qualitative research to facilitate the interpretation of quantitative results from a discrete choice experiment: insights from a survey in elderly ophthalmologic patientsVera Vennedey, Marion Danner, Silvia Maa Evers, et al.
Trials|July 18, 2018
Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trialFriederike Schaub, Robert Hoerster, Petra Schiller, et al.
Plos One|June 4, 2016
Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity StagesTina Schick, Lebriz Altay, Eva Viehweger, et al.
The British Journal of Ophthalmology|July 2, 2011
No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohortPhilipp S Muether, Angela Kribs, Moritz Hahn, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 23, 2012
Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real lifeKatharina M Droege, Philipp S Muether, Manuel M Hermann, et al.
Retina (Philadelphia, Pa.)|July 19, 2011
Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachmentSabine Schröder, Philipp S Muether, Albert Caramoy, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 18, 2013
Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration - monthly injections versus pro re nataKatharina M Droege, Albert Caramoy, Andreas Kersten, et al.
Pageof 24